Anti-Lactate Dehydrogenase Isoenzyme V antibody

• Supplier: Abcam
• Catalog: ab9002
• Prices: $384.00
• Sizes: 500 µl
• Host: Sheep
• Clonality: Polyclonal
• Isotype: IgG
• Applications: IHC-P WB IHC-F
• Species Reactivities: Human
• Antigen: Human Lactate Dehydrogenase V, purified from human placenta
• Description: Sheep Polyclonal
• Gene: LDHA
• Conjugate: Unconjugated

Product images

All lanes : Anti-Lactate Dehydrogenase Isoenzyme V antibody (ab9002) at 1 µg/mlLane 1 : Kidney (Human) Tissue Lysate - adult normal tissue (ab30203)Lane 2 : Liver (Human) Tissue Lysate - adult normal tissue (ab29889)Lane 3 : HEK293 (Human embryonic kidney cell line) Whole Cell LysateLane 4 : HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate Lysates/proteins at 10 µg per lane.SecondaryRabbit polyclonal Secondary Antibody to Sheep IgG - H&L (HRP) at 1/5000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.

Immunohistochemical analysis of Human head and neck cancer tissue, staining Lactate Dehydrogenase Isoenzyme V (red) with ab9002 at 1/100 dilution. Sections were fixed in acetone before being incubated with primary antibody overnight at 4°C. A Cy3-conjugated donkey anti-sheep IgG (1/600) was used as the secondary antibody.

Product References

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate - Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate

Koukourakis MI, Giatromanolaki A, Panteliadou M, Pouliliou SE, Chondrou PS, Mavropoulou S, Sivridis E. Br J Cancer. 2014 Apr 29;110(9):2217-23.

On-target inhibition of tumor fermentative glycolysis as visualized by - On-target inhibition of tumor fermentative glycolysis as visualized by

Seth P, Grant A, Tang J, Vinogradov E, Wang X, Lenkinski R, Sukhatme VP. Neoplasia. 2011 Jan;13(1):60-71.

Metabolic markers in relation to hypoxia; staining patterns and colocalization of - Metabolic markers in relation to hypoxia; staining patterns and colocalization of

Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders JH. BMC Cancer. 2011 May 12;11:167.

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate - Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate

Koukourakis MI, Giatromanolaki A, Sivridis E, Pitiakoudis M, Gatter KC, Harris AL. Br J Cancer. 2010 Oct 12;103(8):1209-14.

Laser microdissection expression profiling of marginal edges of colorectal - Laser microdissection expression profiling of marginal edges of colorectal

Thorn CC, Freeman TC, Scott N, Guillou PJ, Jayne DG. Gut. 2009 Mar;58(3):404-12.

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor - BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor

Giatromanolaki A, Koukourakis MI, Gatter KC, Harris AL, Sivridis E. J Clin Pathol. 2008 Feb;61(2):217-20. Epub 2007 May 18.

Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association - Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association

Kolev Y, Uetake H, Takagi Y, Sugihara K. Ann Surg Oncol. 2008 Aug;15(8):2336-44.

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent - p53-mediated apoptosis of CLL cells: evidence for a transcription-independent

Steele AJ, Prentice AG, Hoffbrand AV, Yogashangary BC, Hart SM, Nacheva EP, Howard-Reeves JD, Duke VM, Kottaridis PD, Cwynarski K, Vassilev LT, Wickremasinghe RG. Blood. 2008 Nov 1;112(9):3827-34.

Comparison of metabolic pathways between cancer cells and stromal cells in - Comparison of metabolic pathways between cancer cells and stromal cells in

Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. Cancer Res. 2006 Jan 15;66(2):632-7.

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer - Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer

Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL. Br J Cancer. 2003 Sep 1;89(5):877-85.